Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • ADX Discusses Cooperation With Korean Counterpart

    Date 16/03/2013

    Abu Dhabi Securities Exchange (ADX) received last week a delegation from Korea Stock Exchange (KRX).  The two parties signed a Memorandum of Understanding in January of the year 2013 and the visit comes to further develop the ongoing cooperation between the exchanges under the terms of the MoU. 

  • IMF Statement On Cyprus At The Eurogroup Meeting

    Date 16/03/2013

    Christine Lagarde, Managing Director of the International Monetary Fund (IMF), issued the following statement today following the Eurogroup meeting:

    “I welcome the agreement reached today to address Cyprus’ economic challenges. The IMF has always said that we would support a solution that is sustainable, that is fully financed, and that appropriately allocates the burden sharing. I believe that the agreed package meets these three objectives. On this basis, I intend to make a recommendation to our Executive Board for the IMF to contribute to the financing of the package.”

  • BATS 1000 Index Rises 0.8% This Week

    Date 15/03/2013

    BATS Global Markets, a leading operator of securities markets in the U.S. and Europe, reports the BATS 1000® Index (Ticker: BATSK) rose 133.59 points, or 0.8%, this week to close at 17,661.31 as of the 4 p.m. ET market close today. 

  • SIFMA Market Close Recommendations For Good Friday And U.K. Easter Monday Holidays In The US, The UK And Japan

    Date 15/03/2013

    In observance of the Good Friday and U.K. Easter Monday holidays, SIFMA made holiday recommendations for the U.S., the U.K., and Japan.

  • SEC: CR Intrinsic Agrees To Pay More than $600 Million In Largest-Ever Settlement For Insider Trading Case

    Date 15/03/2013

    The Securities and Exchange Commission today announced that Stamford, Conn.-based hedge fund advisory firm CR Intrinsic Investors has agreed to pay more than $600 million to settle SEC charges that it participated in an insider trading scheme involving a clinical trial for an Alzheimer’s drug being jointly developed by two pharmaceutical companies.